Case-Control Study to Identify Risk Factors for Microscopic Colitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

487 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-07-31

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to assess among others environmental and hygiene-related risk factors for microscopic colitis (MC), a common diarrheal disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection

NCT04668014

Clostridioides Difficile Infection

COMPLETED

A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis

NCT02618187

Ulcerative Colitis

COMPLETED PHASE1

Assessment of Patients With Acute Pouchitis Treated With Antibiotics

NCT05252273

Pouchitis Ulcerative Colitis

SUSPENDED

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

NCT04043897

Microscopic Colitis

RECRUITING PHASE2

FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis

NCT06206707

Diarrhea Colitis Malignant Melanoma +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Microscopic Colitis Collagenous Colitis Lymphocytic Colitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Microscopic Colitis

Group consists of subjects diagnosed with either collagenous of lymphocytic colitis between January 1, 2000 and December 31, 2012

Whole saliva sample

Intervention Type OTHER

Both case and control group will be approached to consider to give permission to sample saliva. This is not obligatory. Collected samples will be stored for future DNA research.

Healthy Controls

Control group consists of subjects with no history of microscopic colitis. Group is age and sex matched with the case-group

Whole saliva sample

Intervention Type OTHER

Both case and control group will be approached to consider to give permission to sample saliva. This is not obligatory. Collected samples will be stored for future DNA research.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whole saliva sample

Both case and control group will be approached to consider to give permission to sample saliva. This is not obligatory. Collected samples will be stored for future DNA research.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed Diagnosis of MC (CC or LC) between January 1, 2000 and December 31, 2012.
* Inhabitant of the province of Limburg or the Eindhoven region at the moment of diagnosis